Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Zhongbao Pharmaceutical is a Chinese pharmaceutical company specializing in the development, manufacturing, and distribution of chemical drug formulations and active pharmaceutical ingredients (APIs). The company's core therapeutic focus includes anti-infectives, cardiovascular health, and gastroenterology, with a product line featuring widely used generic antibiotics like cephalosporins and macrolides. Based in Hangzhou, the firm operates multiple GMP-certified production facilities that supply essential medicines to the Chinese domestic market. Zhongbao Pharmaceutical is recognized for its robust manufacturing capabilities and its role as a key subsidiary of the Zhejiang Zhongbao Industrial Group. The company continues to expand its portfolio of generic medications to address prevalent health conditions such as hypertension and bacterial infections.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhongbao.